DRW Securities’s Halozyme HALO Stock Holding History

DRW Securities’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,422	Closed	-$230K	–	1481
2025 Q4	$230K	Buy	+3,422	New	+$230K	0.01%	857

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DRW Securities's HALO Position: Q1 2026 in Review

DRW Securities sold out of Halozyme (HALO) in Q1 2026, closing a stake of 3,422 shares — an estimated $230K sold.

DRW Securities first reported a position in HALO in Q4 2025 and held it in 1 quarter. The position peaked at $230K in Q4 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

DRW Securities reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
DRW Securities sold 3,422 Halozyme shares in Q1 2026, an estimated $230K.
DRW Securities first reported a position in Halozyme in Q4 2025 and held it in 1 quarter.
DRW Securities's Halozyme position peaked at $230K in Q4 2025.
634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.